Skip to content
10-K

Annual Report

Exagen Inc. XGN

0001274737-25-000019

← back to feed
Filed
Mar 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 7, 2025 17.9M sh
Shares Diluted FY 2024 · Dec 31, 2023 17.68M sh
Capex FY 2024 · Dec 31, 2023 $828K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$14.46M
Long Term Debt FY 2024 · Dec 31, 2023 $19.23M
Short Term Debt FY 2024 · Dec 31, 2023 $264K
Cash And Equivalents FY 2024 · Dec 31, 2023 $36.49M
Current Liabilities FY 2024 · Dec 31, 2023 $11.9M
Total Liabilities FY 2024 · Dec 31, 2023 $34.25M
Current Assets FY 2024 · Dec 31, 2023 $47.84M
Total Assets FY 2024 · Dec 31, 2023 $56.94M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.34
Eps Basic FY 2024 · Dec 31, 2023 −$1.34
Sga Expense FY 2024 · Dec 31, 2023 $47.43M
Rd Expense FY 2024 · Dec 31, 2023 $4.87M
Net Income FY 2024 · Dec 31, 2023 −$23.69M
Operating Income FY 2024 · Dec 31, 2023 −$22.84M
Gross Profit FY 2024 · Dec 31, 2023 $29.46M
Revenue FY 2024 · Dec 31, 2023 $52.55M
Stockholders Equity FY 2024 · Dec 31, 2022 $42.46M